• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛛网膜下腔出血患者的脑脊液分析及随时间的变化:一项前瞻性观察研究。

Cerebrospinal fluid analysis and changes over time in patients with subarachnoid hemorrhage: a prospective observational study.

作者信息

Pesaresi Alessandro, Battaglini Denise, Anania Pasquale, Sgambetterra Silvia, Origlia Camilla, Zona Gianluigi, Langer Thomas, Patroniti Nicolò Antonino, Fiaschi Pietro, Robba Chiara

机构信息

Division of Neurosurgery, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Neurosurgery Unit, "Città Della Salute E Della Scienza" University Hospital, Turin, Italy.

出版信息

J Anesth Analg Crit Care. 2025 Jun 12;5(1):31. doi: 10.1186/s44158-025-00250-1.

DOI:10.1186/s44158-025-00250-1
PMID:40506779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12160409/
Abstract

BACKGROUND

Changes in cerebrospinal fluid (CSF) in patients with aneurysmal subarachnoid hemorrhage (aSAH) have not been fully elucidated, yet they are critical and may potentially be associated with the risk of complications. The aim of this study is to characterize the biochemical properties of CSF and examine the temporal changes in aSAH patients with and without post-aSAH complications such as vasospasm and shunt-dependent hydrocephalus.

METHODS

This prospective observational longitudinal cohort study involved collecting CSF and arterial blood samples from SAH patients requiring an external ventricular drain at four different timepoints following the initial event (1-3, 4-7, 8-13, and 14-20 days after aSAH). A control group that comprised patients with idiopathic normal pressure hydrocephalus undergoing CSF sampling was included.

RESULTS

A total of 20 SAH patients and 20 controls were enrolled. We observed significantly higher levels of hemoglobin (Hb), proteins, lactate, and cell concentrations in the CSF of aSAH patients compared to the control group (p < 0.001), with no corresponding differences in serum levels. Furthermore, a progressive decline in CSF Hb, proteins, and cells levels was noted over the days following the hemorrhage (p = 0.029, p = 0.005, and p = 0.010, respectively). Patients that developed vasospasm exhibited a lower CSF glucose/lactate ratio (p < 0.001) and reduced CSF sodium levels (p = 0.045), while patients that developed shunt-dependent hydrocephalus exhibited higher plasmatic and CSF glucose levels (p = 0.013 and p = 0.003, respectively) and lower CSF Hb/proteins ratio (p < 0.001).

CONCLUSIONS

Patients with aSAH exhibit changes in the biochemical profile of the CSF, which evolve over time following the acute event. Parameters such as CSF glucose/lactate ratio and CSF Hb/proteins ratio could potentially provide valuable insights not only into the pathophysiology of aSAH but also into patient risks of post-hemorrhagic complications, such as vasospasm and hydrocephalus.

摘要

背景

动脉瘤性蛛网膜下腔出血(aSAH)患者脑脊液(CSF)的变化尚未完全阐明,但这些变化至关重要,可能与并发症风险相关。本研究的目的是描述CSF的生化特性,并研究有和没有aSAH后并发症(如血管痉挛和分流依赖性脑积水)的aSAH患者的时间变化。

方法

这项前瞻性观察性纵向队列研究包括在初始事件后的四个不同时间点(aSAH后1 - 3天、4 - 7天、8 - 13天和14 - 20天)从需要进行外部脑室引流的SAH患者中采集CSF和动脉血样本。纳入了一个由接受CSF采样的特发性正常压力脑积水患者组成的对照组。

结果

共纳入20例SAH患者和20例对照。我们观察到,与对照组相比,aSAH患者CSF中的血红蛋白(Hb)、蛋白质、乳酸和细胞浓度显著更高(p < 0.001),血清水平无相应差异。此外,出血后的几天内,CSF中的Hb、蛋白质和细胞水平逐渐下降(分别为p = 0.029、p = 0.005和p = 0.010)。发生血管痉挛的患者CSF葡萄糖/乳酸比值较低(p < 0.001)且CSF钠水平降低(p = 0.045),而发生分流依赖性脑积水的患者血浆和CSF葡萄糖水平较高(分别为p = 0.013和p = 0.003)且CSF Hb/蛋白质比值较低(p < 0.001)。

结论

aSAH患者的CSF生化特征会发生变化,这些变化在急性事件后随时间演变。CSF葡萄糖/乳酸比值和CSF Hb/蛋白质比值等参数不仅可能为aSAH的病理生理学提供有价值的见解,还可能为出血后并发症(如血管痉挛和脑积水)的患者风险提供有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/830d/12160409/aff5db37e1ad/44158_2025_250_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/830d/12160409/fae8b11c482c/44158_2025_250_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/830d/12160409/aff5db37e1ad/44158_2025_250_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/830d/12160409/fae8b11c482c/44158_2025_250_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/830d/12160409/aff5db37e1ad/44158_2025_250_Fig2_HTML.jpg

相似文献

1
Cerebrospinal fluid analysis and changes over time in patients with subarachnoid hemorrhage: a prospective observational study.蛛网膜下腔出血患者的脑脊液分析及随时间的变化:一项前瞻性观察研究。
J Anesth Analg Crit Care. 2025 Jun 12;5(1):31. doi: 10.1186/s44158-025-00250-1.
2
The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury.HeMoVal 研究方案:一项前瞻性国际多中心队列研究,旨在验证脑脊液血红蛋白作为蛛网膜下腔出血相关继发性脑损伤的监测生物标志物。
BMC Neurol. 2022 Jul 18;22(1):267. doi: 10.1186/s12883-022-02789-w.
3
Early permanent cerebrospinal fluid diversion in aneurysmal subarachnoid hemorrhage: does a lower rate of nosocomial meningitis outweigh the risk of delayed cerebral vasospasm related morbidity?动脉瘤性蛛网膜下腔出血患者早期行永久性脑脊液分流术:降低院内脑膜炎发生率的获益是否大于延迟性脑血管痉挛相关发病率增加的风险?
Neurol Res. 2021 Jan;43(1):40-53. doi: 10.1080/01616412.2020.1819091. Epub 2020 Oct 26.
4
Cerebrospinal Fluid Lactate and Glucose Levels as Predictors of Symptomatic Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage.脑脊髓液乳酸和葡萄糖水平作为预测动脉瘤性蛛网膜下腔出血患者症状性迟发性脑缺血的指标。
World Neurosurg. 2023 Feb;170:e596-e602. doi: 10.1016/j.wneu.2022.11.068. Epub 2022 Nov 18.
5
Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications.颅内动脉瘤性蛛网膜下腔出血患者的系统性白细胞介素-6 水平升高是蛛网膜下腔出血后并发症的非特异性标志物。
Int J Mol Sci. 2017 Dec 1;18(12):2580. doi: 10.3390/ijms18122580.
6
Intrathecal lactate predicting hydrocephalus after aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血后鞘内乳酸水平对脑积水的预测作用
J Surg Res. 2015 Dec;199(2):523-8. doi: 10.1016/j.jss.2014.09.022. Epub 2014 Sep 28.
7
Temporal Changes in CSF Cell Parameters After SAH: Comparison of Ventricular and Spinal Drain Samples.蛛网膜下腔出血后脑脊液细胞参数的时间变化:脑室引流与椎管引流样本的比较。
Neurocrit Care. 2024 Aug;41(1):194-201. doi: 10.1007/s12028-024-01942-2. Epub 2024 Feb 14.
8
Role of Cerebrospinal Fluid Markers for Predicting Shunt-Dependent Hydrocephalus in Patients with Subarachnoid Hemorrhage and External Ventricular Drain Placement.脑脊液标志物在预测蛛网膜下腔出血和外置脑室引流患者分流依赖型脑积水方面的作用
World Neurosurg. 2019 Jan;121:e535-e542. doi: 10.1016/j.wneu.2018.09.159. Epub 2018 Sep 27.
9
Elevated level of cerebrospinal fluid and systemic chemokine CCL5 is a predictive biomarker of clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH).脑脊液和系统趋化因子 CCL5 水平升高是动脉瘤性蛛网膜下腔出血 (aSAH) 后临床转归的预测生物标志物。
Cytokine. 2020 Sep;133:155142. doi: 10.1016/j.cyto.2020.155142. Epub 2020 May 30.
10
The effect of temporary CSF diversion modality on shunt-dependency following aneurysmal subarachnoid hemorrhage: A nationwide assessment.临时脑脊液分流方式对动脉瘤性蛛网膜下腔出血后分流依赖的影响:一项全国性评估。
J Clin Neurosci. 2025 Feb;132:111008. doi: 10.1016/j.jocn.2024.111008. Epub 2024 Dec 27.

本文引用的文献

1
SAH is a major metabolic sensor mediating worsening metabolic crosstalk in metabolic syndrome.蛛网膜下腔出血是一种主要的代谢传感器,介导代谢综合征中代谢串扰的恶化。
Redox Biol. 2024 Jul;73:103139. doi: 10.1016/j.redox.2024.103139. Epub 2024 Apr 27.
2
Early versus delayed mobilization after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of efficacy and safety.早期与延迟性动脉瘤性蛛网膜下腔出血后移动:有效性和安全性的系统评价和荟萃分析。
Neurosurg Focus. 2023 Dec;55(6):E11. doi: 10.3171/2023.9.FOCUS23548.
3
Sodium and Its Impact on Outcome After Aneurysmal Subarachnoid Hemorrhage in Patients With and Without Delayed Cerebral Ischemia.
钠及其对伴或不伴迟发性脑缺血的动脉瘤性蛛网膜下腔出血患者预后的影响
Crit Care Med. 2024 May 1;52(5):752-763. doi: 10.1097/CCM.0000000000006182. Epub 2024 Jan 11.
4
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association.2023 颅内动脉瘤性蛛网膜下腔出血患者管理指南:美国心脏协会/美国卒中协会指南
Stroke. 2023 Jul;54(7):e314-e370. doi: 10.1161/STR.0000000000000436. Epub 2023 May 22.
5
Guidelines for the Neurocritical Care Management of Aneurysmal Subarachnoid Hemorrhage.《动脉瘤性蛛网膜下腔出血神经重症监护管理指南》。
Neurocrit Care. 2023 Aug;39(1):1-28. doi: 10.1007/s12028-023-01713-5. Epub 2023 May 18.
6
Cerebrospinal Fluid Protein Concentrations in Hydrocephalus.脑积水患者的脑脊液蛋白浓度
Children (Basel). 2023 Mar 30;10(4):644. doi: 10.3390/children10040644.
7
Compartmental Cerebrospinal Fluid Events Occurring after Subarachnoid Hemorrhage: An "Heparin Oriented" Systematic Review.颅内蛛网膜下腔出血后发生的隔室性脑脊液事件:一项“肝素导向”的系统综述。
Int J Mol Sci. 2023 Apr 25;24(9):7832. doi: 10.3390/ijms24097832.
8
VPS dependency after aneurysmal subarachnoid haemorrhage and influence of admission hyperglycaemia.动脉瘤性蛛网膜下腔出血后的VPS依赖性及入院时高血糖的影响
Eur Stroke J. 2023 Mar;8(1):301-308. doi: 10.1177/23969873221147087. Epub 2022 Dec 28.
9
Hemoglobin Derived from Subarachnoid Hemorrhage-Induced Pyroptosis of Neural Stem Cells via ROS/NLRP3/GSDMD Pathway.蛛网膜下腔出血诱导神经干细胞焦亡产生的血红蛋白通过 ROS/NLRP3/GSDMD 通路。
Oxid Med Cell Longev. 2023 Jan 16;2023:4383332. doi: 10.1155/2023/4383332. eCollection 2023.
10
Cerebrospinal Fluid Lactate and Glucose Levels as Predictors of Symptomatic Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage.脑脊髓液乳酸和葡萄糖水平作为预测动脉瘤性蛛网膜下腔出血患者症状性迟发性脑缺血的指标。
World Neurosurg. 2023 Feb;170:e596-e602. doi: 10.1016/j.wneu.2022.11.068. Epub 2022 Nov 18.